Your browser doesn't support javascript.
loading
Dental Implant Failure Risk in Post Oncological Patients, a Retrospective Study and Sapienza Head and Neck Unit Decisional Protocol- 7 Years of Follow-Up.
Brauner, Edoardo; Valentini, Valentino; Romeo, Umberto; Cantore, Marco; Laudoni, Federico; Rajabtork Zadeh, Oriana; Formisano, Valeria; Cassoni, Andrea; Della Monaca, Marco; Battisti, Andrea; Mezi, Silvia; Cirillo, Alessio; De Felice, Francesca; Botticelli, Andrea; Tombolini, Vincenzo; De Vincentiis, Marco; Colizza, Andrea; Tenore, Gianluca; Polimeni, Antonella; Di Carlo, Stefano.
Afiliación
  • Brauner E; Department of Oral and Maxillofacial Sciences, Sapienza University of Rome, Via Caserta 6, 00161 Rome, Italy.
  • Valentini V; Department of Oral and Maxillofacial Sciences, Sapienza University of Rome, Via Caserta 6, 00161 Rome, Italy.
  • Romeo U; Department of Oral and Maxillofacial Sciences, Sapienza University of Rome, Via Caserta 6, 00161 Rome, Italy.
  • Cantore M; Independent Researcher, Corso Italia 19, 58015 Orbetello, Italy.
  • Laudoni F; Independent Researcher, via Garibaldi 141, 00012 Guidonia, Italy.
  • Rajabtork Zadeh O; Department of Oral and Maxillofacial Sciences, Sapienza University of Rome, Via Caserta 6, 00161 Rome, Italy.
  • Formisano V; Independent Researcher, via Raffaele Cadorna 29, 00187 Rome, Italy.
  • Cassoni A; Department of Oral and Maxillofacial Sciences, Sapienza University of Rome, Via Caserta 6, 00161 Rome, Italy.
  • Della Monaca M; Department of Oral and Maxillofacial Sciences, Sapienza University of Rome, Via Caserta 6, 00161 Rome, Italy.
  • Battisti A; Department of Oral and Maxillofacial Sciences, Sapienza University of Rome, Via Caserta 6, 00161 Rome, Italy.
  • Mezi S; Department of Radiological Oncological and Pathological Science, Sapienza University of Rome, 00185 Rome, Italy.
  • Cirillo A; Department of Radiological Oncological and Pathological Science, Sapienza University of Rome, 00185 Rome, Italy.
  • De Felice F; Department of Radiological Oncological and Pathological Science, Sapienza University of Rome, 00185 Rome, Italy.
  • Botticelli A; Department of Radiological Oncological and Pathological Science, Sapienza University of Rome, 00185 Rome, Italy.
  • Tombolini V; Department of Radiological Oncological and Pathological Science, Sapienza University of Rome, 00185 Rome, Italy.
  • De Vincentiis M; Department of Oral and Maxillofacial Sciences, Sapienza University of Rome, Via Caserta 6, 00161 Rome, Italy.
  • Colizza A; Department of Sense Organs, Policlinico Umberto 1 Sapienza University of Rome, viale Regina Elena 326, 00161 Roma, Italy.
  • Tenore G; Department of Oral and Maxillofacial Sciences, Sapienza University of Rome, Via Caserta 6, 00161 Rome, Italy.
  • Polimeni A; Department of Oral and Maxillofacial Sciences, Sapienza University of Rome, Via Caserta 6, 00161 Rome, Italy.
  • Di Carlo S; Department of Oral and Maxillofacial Sciences, Sapienza University of Rome, Via Caserta 6, 00161 Rome, Italy.
Diagnostics (Basel) ; 12(8)2022 Aug 02.
Article en En | MEDLINE | ID: mdl-36010214
ABSTRACT
(1)

Background:

Patients with head and neck cancer are treated by ablative surgery, radiotherapy, chemotherapy, or a combination of these. The side effects of cancer therapies can compromise conventional prosthesis rehabilitation; therefore, dental implants can result in a more effective solution. The aim of the study is to explain how to rehabilitate a patient that underwent head and neck cancer therapy. (2)

Methods:

This retrospective study conducted from 2015 to 2021 included 223 postoncological patients, aged between 32 and 80 years old. Eighteen patients did not proceed with any treatment, and two died. Therefore, 203 patients have been analyzed and rehabilitated following our decisional protocol, with a mean period of follow-up of 4 years. The implant placement was considered successful when a mean bone loss of 1.6 mm for the first year and a mean of 0.13 mm in subsequent years occurred (3)

Results:

A total of 161 patients were rehabilitated with a conventional prosthesis, 42 patients (FM ratio 1923) with an implant-supported prosthesis and a total of 200 implants were placed; 9 implants were lost (4.5% of 200 implants).

Conclusions:

The results confirmed that by following our protocol it is possible to obtain an acceptable rate of implant survival, considering the delicacy and complexity of post-oncological patients.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Etiology_studies / Guideline / Observational_studies / Risk_factors_studies Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Etiology_studies / Guideline / Observational_studies / Risk_factors_studies Idioma: En Año: 2022 Tipo del documento: Article